CompletedNot Applicable

Prolactin Levels in Type 2 Diabetic Patients With Stage III Periodontitis

Egypt80 participantsStarted 2024-10-01

Plain-language summary

evaluate the role of prolactin hormone in the pathogenesis of periodontitis by assessing its local gingival levels and assess clinical parameters in patients who have type two diabetes

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age range from 18 to 60 years * Stage III periodontitis * Type 2 diabetes * Only patients signing informed written consents Exclusion Criteria: * Pregnancy or lactation * Any known systemic disease * Any type of previous periodontal treatment (surgical or non-surgical) in the preceding 6 months * Smoking (former or current)

What they're measuring

Change in Prolactin Hormone Levels in Gingival Crevicular Fluid

Timeframe: Baseline and 3 months after non-surgical periodontal treatment

Trial details

NCT IDNCT06941246

SponsorFaculty of Dental Medicine for Girls

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Type 2 Diabetes Mellitus trials